nach oben

Erschienen in:

01.10.2019 | Child and Adolescent Disorders (TD Benton, Section editor)

Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies

verfasst von: Matthew C. Fadus, Lindsay M. Squeglia, Emilio A. Valadez, Rachel L. Tomko, Brittany E. Bryant, Kevin M. Gray

Erschienen in: Current Psychiatry Reports | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To examine the most recent published evidence (2016–2019) regarding the treatment of adolescent substance use disorders and to provide an update on evidence-based strategies, adjunctive interventions, and methods to improve currently established treatment approaches.

Recent Findings

Recent evidence suggests that psychosocial treatments such as family-based therapy, cognitive behavioral therapy, and multicomponent approaches remain the most effective methods of treatment; however, innovative ways of improving these treatment strategies may include digital and culturally based interventions. New advances in adjunctive treatments such as pharmacotherapy, exercise, mindfulness, and recovery-oriented educational centers may have some clinical utility.

Summary

Well-established psychosocial interventions remain the primary modality of treatment. Promising new adjunctive treatments and improvements in our currently established treatments may yield significant improvements.

Substance Abuse and Mental Health Services Administration: Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16–4984, NSDUH Series H-51). Retrieved from http://www.samhsa.gov/data/. 2016.

Adolescent Substance Use: America’s #1 Public Health Problem. A Report by The National Center on Addiction and Substance Abuse (CASA) Columbia June 29, 2011. 2011.

Dawson DA, Goldstein RB, Chou SP, Ruan WJ, Grant BF. Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res. 2008;32:2149–60.CrossRef

Welsh JW, Knight JR, Hou SS, Malowney M, Schram P, Sherritt L, et al. Association between substance use diagnoses and psychiatric disorders in an adolescent and young adult clinic-based population. J Adolesc Health. 2017;60(6):648–52. https://doi.org/10.1016/j.jadohealth.2016.12.018.CrossRefPubMed

Heradstveit O, Skogen JC, Hetland J, Hysing M. Alcohol and illicit drug use are important factors for school-related problems among adolescents. Front Psychol. 2017;8:1023.CrossRef

Gray KM, Squeglia LM. Research review: what have we learned about adolescent substance use? J Child Psychol Psychiatry Allied Discip. 2018;59:618–27.CrossRef

Squeglia LM, Gray KM. Alcohol and drug use and the developing brain. Curr Psychiatry Rep. 2016;18:46.CrossRef

Belendiuk KA, Riggs P. Treatment of adolescent substance use disorders. Curr Treat Opt Psychiatry. 2014;1:175–88. https://doi.org/10.1007/s40501-014-0016-3.CrossRef

Hogue A, Henderson C, Becker S, Knight D. Evidence base on outpatient behavioral treatments for adolescent substance use, 2014–2017: outcomes, treatment delivery, and promising horizons. J Clin Child Adolesc Psychol. 2018;47(4):499–526. https://doi.org/10.1080/15374416.2018.1466307.CrossRefPubMed

10.

Nathan PE, Gorman JM. Efficacy, effectiveness, and the clinical utility of psychotherapy research. In: Nathan PE, Gorman JM, editors. A guide to treatments that work. 2nd ed. New York, NY: Oxford University Press; 2002. p. 642–54.

11.

Hogue A, Henderson CE, Ozechowski TJ, Robbins MS. Evidence base on outpatient behavioral treatments for adolescent substance use: updates and recommendations 2007–2013. J Clin Child Adolesc Psychol. 2014;43:695–720. https://doi.org/10.1080/15374416.2014.915550.CrossRefPubMed

12.

LoBraico EJ, Fosco GM, Crowley DM, Redmond C, Spoth RL, Feinberg ME. Examining intervention component dosage effects on substance use initiation in the strengthening families program: for parents and youth ages 10–14. Prev Sci. 2019. https://doi.org/10.1007/s11121-019-00994-7.CrossRef

13.

• Bo A, Hai A, Jaccard J. Parent-based interventions on adolescent alcohol use outcomes: a systematic review and meta-analysis. Drug Alcohol Depend. 2018;191:98–109. https://doi.org/10.1016/j.drugalcdep.2018.05.031. This meta-analysis reviews the efficacy of parent-based interventions for adolescent alcohol use, demonstrating that broad, general parenting interventions are just as important as alcohol-specific interventions.CrossRefPubMed

14.

Van der Pol TM, Hoeve M, Noom MJ, Stams GJ, Doreleijers TA, Domburgh LV, et al. Research review: the effectiveness of multidimensional family therapy in treating adolescents with multiple behavior problems - a meta-analysis. J Child Psychol Psychiatry. 2017;58(5):532–45. https://doi.org/10.1111/jcpp.12685.CrossRefPubMed

15.

• Liddle HA, Dakof GA, Rowe CL, Henderson C, Greenbaum P, Wang W, et al. Multidimensional family therapy as a community-based alternative to residential treatment for adolescents with substance use and co-occurring mental health disorders. J Subst Abus Treat. 2018;90:47–56. https://doi.org/10.1016/j.jsat.2018.04.011. This study is an RCT which compares the effectiveness of MDFT to residential treatment. It found no significant therapeutic differences between the two, indicating that adolescents who meet criteria for residential treatment may be adequately managed in an outpatient setting with MDFT.CrossRef

16.

Pol TM, Hendriks V, Rigter H, Cohn MD, Doreleijers TAH, Domburgh L, et al. Multidimensional family therapy in adolescents with a cannabis use disorder: long-term effects on delinquency in a randomized controlled trial. Child Adolesc Psychiatry Ment Health. 2018;12(1). https://doi.org/10.1186/s13034-018-0248-x.

17.

Goorden M, van der Schee E, Hendriks VM, Hakkaart-van Roijen L. Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: data from a randomized controlled trial. Drug Alcohol Depend. 2016;162:154–61 10.1016/j.drugalcdep.2016.03.004.CrossRef

18.

Brewer S, Godley MD, Hulvershorn LA. Treating mental health and substance use disorders in adolescents: what is on the menu? Curr Psychiatry Rep. 2017;19:5. https://doi.org/10.1007/s11920-017-0755-0.CrossRefPubMed

19.

Stanger C, Lansing AH, Budney AJ. Advances in research on contingency management for adolescent substance use. Child Adolesc Psychiatr Clin N Am. 2016;25:645–59. https://doi.org/10.1016/j.chc.2016.05.002.CrossRefPubMedPubMedCentral

20.

Stanger C, Scherer EA, Babbin SF, Ryan SR, Budney AJ. Abstinence based incentives plus parent training for adolescent alcohol and other substance misuse. Psychol Addict Behav. 2017;31(4):385–92 10.1037/adb0000279.CrossRef

21.

Kelly JF, Kaminer Y, Kahler CW, Hoeppner B, Yetarian J, Cristello JV, et al. A pilot randomized clinical trial testing integrated 12-step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction. 2017;112:2155–66. https://doi.org/10.1111/add.13920.CrossRefPubMedPubMedCentral

22.

Spirito A, Hernandez L, Cancilliere MK, Graves HR, Rodriguez AM, Operario D, et al. Parent and adolescent motivational enhancement intervention for substance-using, truant adolescents: a pilot randomized trial. J Clin Child Adolesc Psychol. 2018;47(Suppl 1):S467–79 10.1080/15374416.2017.1399402.CrossRef

23.

Thurstone C, Hull M, Timmerman J, Emrick C. Development of a motivational interviewing/acceptance and commitment therapy model for adolescent substance use treatment. J Contextual Behav Sci. 2017;6(4):375–9. https://doi.org/10.1016/j.jcbs.2017.08.00.CrossRef

24.

Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent treatment of substance use and PTSD. Curr Psychiatry Rep. 2016;18(8):70. https://doi.org/10.1007/s11920-016-0709-y.CrossRefPubMedPubMedCentral

25.

Danielson, C. K., Adams, Z. A., & Hanson, R. (2019). Risk Reduction through Family Therapy (RRFT): exposure-based treatment for co-occurring PTSD and substance use problems among adolescents (pgs. 165–182). In A. A. Vujanovic & S. E. Back (Eds.), Posttraumatic stress and substance use disorders: a comprehensive clinical handbook. New York: Routledge.

26.

Cohen JA, Mannarino AP, Deblinger E. Treating trauma and traumatic grief in children and adolescents. New York, NY: Guilford Press; 2006.

27.

Henggeler SW. Multisystemic therapy for antisocial behavior in children and adolescents. 2nd ed. New York, NY: Guilford Press; 2009.

28.

Danielson CK, Adams ZW, Chapman J, McCart MM, Sheidow A, Walker J, Smalling A & de Arellano M. The safety and efficacy of exposure-based treatment of co-occurring substance use problems and PTSD among adolescents: a randomized controlled trial of Risk Reduction through Family Therapy (RRFT). Manuscript submitted for publication. 2019.

29.

Knight DK, Joe GW, Becan JE, Crawley RD, Theisen SE, Flynn PM. Effectiveness of an intervention for improving intrinsic motivation among adolescent males in a secure substance use treatment setting. Crim Justice Behav. 2019;46(1):101–14. https://doi.org/10.1177/0093854818804857.CrossRef

30.

Li L, Zhu S, Tse N, Tse S, Wong P. Effectiveness of motivational interviewing to reduce illicit drug use in adolescents: a systematic review and meta-analysis. Addiction. 2016;111(5):795–805. https://doi.org/10.1111/add.13285.CrossRefPubMed

31.

Carney T, Myers BJ, Louw J, Okwundu CI. Brief school-based interventions and behavioural outcomes for substance-using adolescents (Review). Cochrane Database Syst Rev 2014;CD008969.

32.

• D’Amico EJ, Parast L, Shadel WG, Meredith LS, Seelam R, Stein BD. Brief motivational interviewing intervention to reduce alcohol and marijuana use for at-risk adolescents in primary care. J Consult Clin Psychol. 2018;86(9):775–86. https://doi.org/10.1037/ccp0000332. This RCT demonstrated that brief motivational interviewing sessions performed in primary care settings can effect lasting changes in alcohol and cannabis use over one year later in adolescents.CrossRefPubMedPubMedCentral

33.

Dembo R, Briones-Robinson R, Schmeidler J, Wareham J, Ungaro R, Winters KC, et al. Brief intervention impact on truant youths’ marijuana use: eighteen-month follow-up. J Child Adolesc Subst Abuse. 2016;25(1):18–32. https://doi.org/10.1080/1067828X.2013.872068.CrossRef

34.

Laporte C, Vaillant-Roussel H, Pereira B, Blanc O, Eschalier B, Kinouani S, et al. Cannabis and young users-a brief intervention to reduce their consumption (CANABIC): a cluster randomized controlled trial in primary care. Ann Fam Med. 2017;15(2):131–9. https://doi.org/10.1370/afm.2003.CrossRefPubMedPubMedCentral

35.

Newton AS, Dow N, Dong K, Fitzpatrick E, Cameron Wild T, Johnson DW, et al. A randomised controlled pilot trial evaluating feasibility and acceptability of a computer-based tool to identify and reduce harmful and hazardous drinking among adolescents with alcohol-related presentations in Canadian pediatric emergency departments. BMJ Open. 2017;7(8):e015423. https://doi.org/10.1136/bmjopen-2016-015423.CrossRefPubMedPubMedCentral

36.

Becker SJ, Jones RN, Hernandez L, Graves HR, Spirito A. Moderators of brief motivation-enhancing treatments for alcohol-positive adolescents presenting to the emergency department. J Subst Abus Treat. 2016;69:28–34. https://doi.org/10.1016/j.jsat.2016.06.014.CrossRef

37.

Wurdak M, Wolstein J, Kuntsche E. Effectiveness of a drinking-motive-tailored emergency-room intervention among adolescents admitted to hospital due to acute alcohol intoxication - a randomized controlled trial. Prev Med Rep. 2016;3:83–9. https://doi.org/10.1016/j.pmedr.2015.12.009.CrossRefPubMed

38.

Conde K, Brandariz RA, Lichtenberger A, Cremonte M. The effectiveness of a brief intervention for reducing adolescent alcohol consumption. Revista Ciencias De La Salud. 2018;16(3):393–407. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.7261.CrossRef

39.

Stewart D, Siebert E, Arlt V, Moise-Campbell C, Lehinger E. Ready or not: findings from a school-based mi intervention for adolescent substance use. J Subst Abus Treat. 2016;71:23–9. https://doi.org/10.1016/j.jsat.2016.08.007.CrossRef

40.

Walker DD, Stephens RS, Blevins CE, Banes KE, Matthews L, Roffman RA. Augmenting brief interventions for adolescent marijuana users: the impact of motivational check-ins. J Consult Clin Psychol. 2016;84(11):983–92. https://doi.org/10.1037/ccp0000094.CrossRefPubMedPubMedCentral

41.

Fortuna L, Porche M, Padilla A. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder. Psychol Psychother. 2018;91(1):42–62. https://doi.org/10.1111/papt.12143.CrossRefPubMed

42.

Godley SH, Smith JE, Passetti LL, Subramaniam G. The Adolescent Community Reinforcement Approach (A-CRA) as a model paradigm for the management of adolescents with substance use disorders and co-occurring psychiatric disorders. Subst Abus. 2014;35(4):352–63. https://doi.org/10.1080/08897077.2014.936993.CrossRefPubMed

43.

Godley MD, Passetti LL, Subramaniam GA, Funk RR, Smith JE, Meyers RJ. Adolescent Community Reinforcement Approach implementation and treatment outcomes for youth with opioid problem use. Drug Alcohol Depend. 2017;174:9–16. https://doi.org/10.1016/j.drugalcdep.2016.12.029.CrossRefPubMedPubMedCentral

44.

Kaminer Y, Ohannessian C, Burke R. Adolescents with cannabis use disorders: Adaptive treatment for poor responders. Addict Behav. 2017;70:102–6. https://doi.org/10.1016/j.addbeh.2017.02.013.CrossRefPubMed

45.

Kelly JF, Yeterian JD, Cristello JV, Kaminer Y, Kahler CW, Timko C. Developing and testing twelve-step facilitation for adolescents with substance use disorder: manual development and preliminary outcomes. Subst Abuse Res Treat. 2016;10:55–64. https://doi.org/10.4137/SART.S39635.CrossRef

46.

• Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM. Pharmacological treatment of youth substance use disorders. J Child Adolesc Psychopharmacol. 2019. https://doi.org/10.1089/cap.2019.0009. This 2019 review examines the literature for treating adolescent SUDs with adjunctive pharmacotherapy.CrossRef

47.

Levy S, Ryan SA, Gonzalez PK, Patrick SW, Quigley J, Siqueira L, et al. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3). https://doi.org/10.1542/peds.2016-1893.

48.

Borodovsky JT, Levy S, Fishman M, Marsch LA. Buprenorphine treatment for adolescents and young adults with opioid use disorders: a narrative review. J Addict Med. 2018;12:170–83.CrossRef

49.

Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008;300:2003–11.CrossRef

50.

Vo HT, Burgower R, Rozenberg I, Fishman M. Home-based delivery of XR-NTX in youth with opioid addiction. J Subst Abus Treat. 2018;85:84–9. https://doi.org/10.1016/j.jsat.2017.08.007.CrossRef

51.

Marsch LA, Moore SK, Borodovsky JT, Solhkhah R, Badger GJ, Semino S, et al. A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction. 2016;111(8):1406–15 10.1111/add.13363.CrossRef

52.

Miranda R Jr, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, et al. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol. 2014;19:941–54.CrossRef

53.

O’Malley SS, Corbin WR, Leeman RF, DeMartini KS, Fucito LM, Ikomi J, et al. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. J Clin Psychiatry. 2015;76:e207–13.CrossRef

54.

DeMartini KS, Gueorguieva R, Leeman RF, Corbin WR, Fucito LM, Kranzler HR, et al. Longitudinal findings from a randomized clinical trial of naltrexone for young adult heavy drinkers. J Consult Clin Psychol. 2016;84:185–90.CrossRef

55.

Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169:805–12.CrossRef

56.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, et al. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017;177:249–57. https://doi.org/10.1016/j.drugalcdep.2017.04.020.CrossRefPubMedPubMedCentral

57.

Gray KM, Watson NL, Carpenter MJ, Larowe SD. N-Acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010;19:187–9.CrossRef

58.

Killen JD, Robinson TN, Ammerman S, Hayward C, Rogers J, Stone C, et al. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol. 2004;72:729–35.CrossRef

59.

Muramoto ML, Leischow SJ, Sherrill D, Matthews E, Strayer LJ. Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med. 2007;161:1068–74.CrossRef

60.

Gray KM, Carpenter MJ, Lewis AL, Klintworth EM, Upadhyaya HP. Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine Tob Res. 2012;14:234–9.CrossRef

61.

Fadus M, Smith T, Squeglia L. The rise of e-cigarettes, pod mod devices, and juul among youth: factors influencing use, health implications, and downstream effects. Drug Alcohol Depend. 2019;201:85–93. https://doi.org/10.1016/j.drugalcdep.2019.04.011.CrossRefPubMed

62.

Tsai J, Walton K, Coleman B, Sharapova S, Johnson S, Kennedy S, et al. Reasons for electronic cigarette use among middle and high school students - national youth tobacco survey, united states, 2016. Mmwr. Morb Mortal Wkly Rep. 2018;67(6):196–200. https://doi.org/10.15585/mmwr.mm6706a5.CrossRef

63.

Myung SK, Park JY. Efficacy of pharmacotherapy for smoking cessation in adolescent smokers: a meta-analysis of randomized controlled trials. Nicotine Tob Res. 2018.

64.

Butzer B, LoRusso A, Shin SH, Khalsa SB. Evaluation of yoga for preventing adolescent substance use risk factors in a middle school setting: a preliminary group-randomized controlled trial. J Youth Adolesc. 2016;46(3):603–32. https://doi.org/10.1007/s10964-016-0513-3.CrossRefPubMedPubMedCentral

65.

More A, Jackson B, Dimmock JA, Thornton AL, Colthart A, Furzer BJ. Exercise in the treatment of youth substance use disorders: review and recommendations. Front Psychol. 2017 8(OCT). https://doi.org/10.3389/fpsyg.2017.01839.

66.

More A, Jackson B, Dimmock JA, Thornton AL, Colthart A, Furzer BJ. “It’s like a counselling session … but you don’t need to say anything:” exercise program outcomes for youth within a drug and alcohol treatment service. Psychol Sport Exerc. 2018;39:1–9. https://doi.org/10.1016/j.psychsport.2018.07.002.CrossRef

67.

Russell BS, Hutchison M, Fusco A. Emotion regulation outcomes and preliminary feasibility evidence from a mindfulness intervention for adolescent substance use. J Child Adolesc Subst Abuse. 2019. https://doi.org/10.1080/1067828X.2018.1561577.CrossRef

68.

Finch A, Tanner-Smith E, Hennessy E, Moberg D. Recovery high schools: effect of schools supporting recovery from substance use disorders. Am J Drug Alcohol Abuse. 2018;44(2):175–84. https://doi.org/10.1080/00952990.2017.1354378.CrossRefPubMed

69.

Buckheit K, Moskal D, Spinola S, Maisto SA, Chung T. Alcohol treatment goal choice predicts longitudinal drinking outcomes in adolescent substance users. J Child Adolesc Subst Abuse. 2018;27(1):1–10. https://doi.org/10.1080/1067828X.2017.1384776.CrossRefPubMed

70.

Kaminer Y, Ohannessian CM, Burke RH. Goal commitment predicts cannabis use for adolescents in treatment. Subst Abus. 2019. https://doi.org/10.1080/08897077.2019.1573207.

71.

Russell KC, Gillis HL, Law L, Couillard J. A pilot study examining outcomes associated with the implementation of progress monitoring at a substance use disorder treatment program for adolescents. Child Youth Care Forum. 2018;47(3):403–19. https://doi.org/10.1007/s10566-018-9437-2.CrossRef

72.

Smedslund G, Nilsen W, Wollscheid S, Steiro A, Fang L, Larun L. Effects of computerized interventions on risky alcohol use among youth: systematic review. Res Soc Work Pract. 2018;2018. https://doi.org/10.1177/1049731518815259.CrossRef

73.

Anderson M, Jiang J. Teens, social media & technology 2018. 2018. Retrieved from https://www.pewinternet.org/2018/05/31/teens-social-media-technology-2018/.

74.

Hoch E, Preuss UW, Ferri M, Simon R. Digital interventions for problematic cannabis users in non-clinical settings: findings from a systematic review and meta-analysis. Eur Addict Res. 2016;22:233–42. https://doi.org/10.1159/000445716-.CrossRefPubMed

75.

Tofighi B, Nicholson JM, McNeely J, Muench F, Lee JD. Mobile phone messaging for illicit drug and alcohol dependence: a systematic review of the literature. Drug Alcohol Rev. 2017;36:477–91. https://doi.org/10.1111/dar.12535.CrossRefPubMed

76.

Haug S, Paz Castro R, Kowatsch T, Filler A, Dey M, Schaub MP. Efficacy of a web- and text messaging-based intervention to reduce problem drinking in adolescents: results of a cluster-randomized controlled trial. J Consult Clin Psychol. 2017;85(2):147–59. https://doi.org/10.1037/ccp0000138.CrossRefPubMed

77.

Hides L, Quinn C, Cockshaw W, Stoyanov S, Zelenko O, Johnson D, et al. Efficacy and outcomes of a mobile app targeting alcohol use in young people. Addict Behav. 2018;77:89–95. https://doi.org/10.1016/j.addbeh.2017.09.020.CrossRefPubMed

78.

Benarous X, Edel Y, Consoli A, Brunelle J, Etter J, Cohen D, Khazaal Y. Ecological momentary assessment and smartphone application intervention in adolescents with substance use and comorbid severe psychiatric disorders: study protocol. Front Psychiatry. 2016;7(SEP). https://doi.org/10.3389/fpsyt.2016.00157.

79.

Hu EM. The effectiveness of text coaching on substance use treatment outcomes in adolescence. Dissertation Abstracts International: Section B: The Sciences and Engineering. ProQuest Information & Learning. 2018. Retrieved from https://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2017-54457-058&site=ehost-live.

80.

Jander A, Crutzen R, Mercken L, Candel M, de Vries H. Effects of a web-based computer-tailored game to reduce binge drinking among dutch adolescents: a cluster randomized controlled trial. J Med Internet Res. 2016;18(2):e29. https://doi.org/10.2196/jmir.4708.CrossRefPubMedPubMedCentral

81.

Jacobus J, Taylor C, Gray K, Meredith L, Porter A, Li I, et al. A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users. Drug Alcohol Depend. 2018;187:195–204. https://doi.org/10.1016/j.drugalcdep.2018.03.007.CrossRefPubMedPubMedCentral

82.

• Arnaud N, Baldus C, Elgán TH, De Paepe N, Tønnesen H, Csémy L, et al. Effectiveness of a web-based screening and fully automated brief motivational intervention for adolescent substance use: a randomized controlled trial. J Med Internet Res. 2016;18(5):e103. https://doi.org/10.2196/jmir.4643. This RCT demonstrated that targeted, brief motivational interventions in an automated, web-based format can be effective to reduce risky drinking among adolescents.CrossRefPubMedPubMedCentral

83.

Braciszewski JM, Tzilos Wernette GK, Moore RS, Bock BC, Stout RL, Chamberlain P. A pilot randomized controlled trial of a technology-based substance use intervention for youth exiting foster care. Child Youth Serv Rev. 2018;94:466–76. https://doi.org/10.1016/j.childyouth.2018.08.011.CrossRefPubMed

84.

Mason MJ, Zaharakis NM, Russell M, Childress V. A pilot trial of text-delivered peer network counseling to treat young adults with cannabis use disorder. J Subst Abus Treat. 2018;89:1–10. https://doi.org/10.1016/j.jsat.2018.03.002.CrossRef

85.

Mason MJ, Zaharakis NM, Moore M, Brown A, Garcia C, Seibers A, et al. Who responds best to text-delivered cannabis use disorder treatment? A randomized clinical trial with young adults. Psychol Addict Behav. 2018;32(7):699–709. https://doi.org/10.1037/adb0000403.CrossRefPubMed

86.

Paz Castro R, Haug S, Kowatsch T, Filler A, Schaub M. Moderators of outcome in a technology-based intervention to prevent and reduce problem drinking among adolescents. Addict Behav. 2017;72:64–71. https://doi.org/10.1016/j.addbeh.2017.03.013.CrossRefPubMed

87.

Norman P, Cameron D, Epton T, Webb TL, Harris PR, Millings A, et al. A randomized controlled trial of a brief online intervention to reduce alcohol consumption in new university students: combining self-affirmation, theory of planned behaviour messages, and implementation intentions. Br J Health Psychol. 2017;23(1):108–27.CrossRef

88.

Bernstein MH, Stein LAR, Neighbors C, Suffoletto B, Carey KB, Ferszt G, et al. A text message intervention to reduce 21st birthday alcohol consumption: evaluation of a two-group randomized controlled trial. Psychol Addict Behav. 2018;32(2):149–61.CrossRef

89.

Brinker T, Holzapfel J, Baudson T, Sies K, Jakob L, Baumert H, et al. Photoaging smartphone app promoting poster campaign to reduce smoking prevalence in secondary schools: the smokerface randomized trial: Design and baseline characteristics. BMJ Open. 2016;6(11):014288. https://doi.org/10.1136/bmjopen-2016-014288.CrossRef

90.

Huckvale K, Torous J, Larsen ME. Assessment of the data sharing and privacy practices of smartphone apps for depression and smoking cessation. JAMA Netw Open. 2019;2(4):e192542. https://doi.org/10.1001/jamanetworkopen.2019.2542.CrossRefPubMedPubMedCentral

91.

Hodge D, Jackson K, Vaughn M. Culturally sensitive interventions and substance use: a meta-analytic review of outcomes among minority youths. Soc Work Res. 2012;36(1):11–9. https://doi.org/10.1093/swr/svs008.CrossRef

92.

• Steinka-Fry K, Tanner-Smith E, Dakof G, Henderson C. Culturally sensitive substance use treatment for racial/ethnic minority youth: a meta-analytic review. J Subst Abus Treat. 2017;75:22–37. https://doi.org/10.1016/j.jsat.2017.01.006. This meta-analysis found that treatments which incorporated culturally sensitive design and delivery of SUD interventions led to significantly larger reductions in substance use.CrossRef

93.

Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Queen B, et al. Youth risk behavior surveillance—United States, 2017. MMWR Surveill Summ. 2018;67:1–114.CrossRef

94.

Shih RA, Miles JN, Tucker JS, Zhou AJ, D’Amico EJ. Racial/ethnic differences in adolescent substance use: mediation by individual, family, and school factors. J Stud Alcohol Drugs. 2010;71(5):640–51.CrossRef

95.

Burrow-Sánchez JJ, Hops H. A randomized trial of culturally accommodated versus standard group treatment for Latina/o adolescents with substance use disorders: posttreatment through 12- month outcomes. Cult Divers Ethn Minor Psychol. 2018. https://doi.org/10.1037/cdp0000249.CrossRef

96.

Marsiglia FF, Ayers SL, Han SY, Weide A. The role of culture of origin on the effectiveness of a parents-involved intervention to prevent substance use among latino middle school youth: results of a cluster randomized controlled trial. Prev Sci. 2018. https://doi.org/10.1007/s11121-018-0968-4.CrossRef

97.

Alegria M, Carson NJ, Goncalves M, Keefe K. Disparities in treatment for substance use disorders and co-occurring disorders for ethnic/racial minority youth. J Am Acad Child Adolesc Psychiatry. 2011;50(1):22–31. https://doi.org/10.1016/j.jaac.2010.10.005.CrossRefPubMed

98.

Lipperman-Kreda S, Grube JW. Impacts of marijuana commercialization on adolescents’ marijuana beliefs, use, and co-use with other substances. J Adolesc Health. 2018;63(1):5–6. https://doi.org/10.1016/j.jadohealth.2018.05.003.CrossRefPubMedPubMedCentral

99.

Scott JC, Slomiak ST, Jones JD, Rosen A, Moore TM, Gur RC. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75(6):585–95. https://doi.org/10.1001/jamapsychiatry.2018.0335.CrossRefPubMedPubMedCentral

100.

Blest-Hopley G, Giampietro V, Bhattacharyya S. Residual effects of cannabis use in adolescent and adult brains — a meta-analysis of fmri studies. Neurosci Biobehav Rev. 2018;88:26–41.CrossRef

Titel: Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies
verfasst von: Matthew C. Fadus
Lindsay M. Squeglia
Emilio A. Valadez
Rachel L. Tomko
Brittany E. Bryant
Kevin M. Gray
Publikationsdatum: 01.10.2019
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 10/2019
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-019-1086-0

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Typ-2-Diabetes und Depression folgen oft aufeinander

Darf man die Behandlung eines Neonazis ablehnen?

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

Update Psychiatrie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2019

Mental Health Issues in Racial and Ethnic Minority Elderly

Sexuality and the Older Adult

Fatal and Non-fatal Self-Injury in the USA: Critical Review of Current Trends and Innovations in Prevention

Depression Treatment Expenditures for Adults in the USA: a Systematic Review

The Family Support Movement and Schizophrenia in India

Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Typ-2-Diabetes und Depression folgen oft aufeinander

Darf man die Behandlung eines Neonazis ablehnen?

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

Update Psychiatrie